Bexion Pharmaceuticals
Covington, United States
Nikhil Wilkins is a research scientist for Bexion Pharmaceuticals. Bexion is looking to improve the chemotherapuetic space with a novel sphingolipid activator, BXQ-350. Nikhil works in the R&D department at Bexion, looking into the mechanisms of action of BXQ-350 and providing in vitro and molecular genetic data to support pre-clinical applications and clinical trials.